Impact of an eHealth Smartphone App on Quality of Life and Clinical Outcome of Patients With Hand and Foot Eczema: Prospective Randomized Controlled Intervention Study

被引:5
|
作者
Weigandt, Wanja Alexander [1 ]
Schardt, Yannic [1 ]
Bruch, Aimee [1 ]
Herr, Raphael [2 ]
Goebeler, Matthias [3 ]
Benecke, Johannes [1 ]
Schmieder, Astrid [3 ]
机构
[1] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, Mannheim, Germany
[2] Heidelberg Univ, Med Fac Mannheim, Ctr Prevent Med & Digital Hlth Baden Wurttemberg C, Mannheim, Germany
[3] Univ Hosp Wurzburg, Dept Dermatol Venereol & Allergol, Josef Schneider Str 2, D-97080 Wurzburg, Germany
来源
JMIR MHEALTH AND UHEALTH | 2023年 / 11卷 / 01期
关键词
hand and foot eczema; eHealth; mobile health; mHealth; telemedicine; disease management; smartphone app; mobile phone; SEVERITY INDEX; EPIDEMIOLOGY; PREVALENCE; PSORIASIS;
D O I
10.2196/38506
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Chronic hand and foot eczema is a polyetiological dermatological condition. Patients experience pain, itching, and sleep disturbances and have a reduced quality of life. Skin care programs and patient education can improve the clinical outcome. eHealth devices offer a new opportunity to better inform and monitor patients.Objective: This study aimed to systematically analyze the effect of a monitoring smartphone app combined with patient education on the quality of life and clinical outcome of patients with hand and foot eczema.Methods: Patients in the intervention group received an educational program; attended study visits on weeks 0, 12, and 24; and had access to the study app. Patients in the control group attended the study visits only. The primary end point was a statistically significant reduction in Dermatology Life Quality Index, pruritus, and pain at weeks 12 and 24. The secondary end point was a statistically significant reduction in the modified Hand Eczema Severity Index (HECSI) score at weeks 12 and 24. This is an interim analysis at week 24 of the 60-week randomized controlled study.Results: In total, 87 patients were included in the study and randomized to the intervention group (n=43, 49%) or control group (n=44, 51%). Of the 87 patients, 59 (68%) completed the study visit at week 24. There were no significant differences between the intervention and control groups regarding quality of life, pain, itch, activity, and clinical outcome at weeks 12 and 24. Subgroup analysis revealed that, compared with the control group, the intervention group with an app use frequency of fewer than once every 5 weeks had a significant improvement in the Dermatology Life Quality Index at weeks 12 (P=.001) and 24 (P=.05), in pain measured on a numeric rating scale at weeks 12 (P=.02) and 24 (P=.02), and in the HECSI score at week 12 (P=.02). In addition, the HECSI scores assessed on the basis of pictures taken by the patients of their hands and feet correlated strongly with the HECSI scores recorded by physicians during regular personal visits (r=0.898; P=.002) even when the quality of the images was not that good.Conclusions: An educational program combined with a monitoring app that connects patients with their treating dermatologists can improve quality of life if the app is not used too frequently. In addition, telemedical care can at least partially replace personal care in patients with hand and foot eczema because the analysis of the pictures taken by the patients correlates strongly with that of the in vivo images. A monitoring app such as the one presented in this study has the potential to improve patient care and should be implemented in daily practice.Trial Registration: Deutsches Register Klinischer Studien DRKS00020963; https://drks.de/search/de/trial/DRKS00020963 (JMIR Mhealth Uhealth 2023;11:e38506) doi: 10.2196/38506
引用
收藏
页数:15
相关论文
共 50 条
  • [31] The impact of metformin use on the clinical outcome of metastatic colorectal cancer patients: A randomized controlled study
    Abdelhafeez, N. M.
    Alorabi, M. O.
    Refaat, G.
    Schaalan, M. F.
    Elwakeel, L.
    Shawki, M. A.
    ANNALS OF ONCOLOGY, 2024, 35 : S24 - S24
  • [32] ANTIREFLUXIVE STENTS: IMPACT ON QUALITY OF LIFE. A PROSPECTIVE RANDOMIZED STUDY
    Krombach, P.
    Wendt-Nordahl, G.
    Alken, P.
    Haecker, A.
    Michel, M. S.
    Knoll, T.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 293 - 293
  • [33] A randomized controlled clinical study on treatment of hand, foot and mouth disease in children with Reduning injection
    Xu Hua-shan
    Zhuo Zhi-qiang
    Chen Bao-chuan
    Jing Jiao
    Zhao Guo-rong
    Wu Jun-feng
    Xiao Wei
    CHINESE MEDICAL JOURNAL, 2013, 126 (13) : 2585 - 2586
  • [34] Lifestyle Intervention on Metabolic Syndrome and its Impact on Quality of Life: A Randomized Controlled Trial
    Saboya, Patricia Pozas
    Bodanese, Luiz Carlos
    Zimmermann, Paulo Roberto
    Gustavo, Andreia da Silva
    Macagnan, Fabricio Edler
    Feoli, Ana Pandolfo
    Oliveira, Margareth da Silva
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2017, 108 (01) : 60 - 68
  • [35] Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study
    Fraterman, Itske
    Sacchi, Lucia
    Mallo, Henk
    Tibollo, Valentina
    Glaser, Savannah Lucia Catherina
    Medlock, Stephanie
    Cornet, Ronald
    Gabetta, Matteo
    Hisko, Vitali
    Khadakou, Vadzim
    Barkan, Ella
    Del Campo, Laura
    Glasspool, David
    Kogan, Alexandra
    Lanzola, Giordano
    Leizer, Roy
    Ottaviano, Manuel
    Peleg, Mor
    Sniatala, Konrad
    Lisowska, Aneta
    Wilk, Szymon
    Parimbelli, Enea
    Quaglini, Silvana
    Rizzo, Mimma
    Locati, Laura Deborah
    Boekhout, Annelies
    Poll-Franse, Lonneke V. van de
    Wilgenhof, Sofie
    JMIR CANCER, 2025, 11
  • [36] Impact on quality of life of alitretinoin in severe chronic hand eczema: FUGETTA real-world study
    Augustin, Matthias
    Thaci, Diamant
    Kamps, Anja
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2016, 14 (12): : 1261 - 1270
  • [37] Impact of a Face-To-Face Versus Smartphone App Versus Combined Breastfeeding Intervention Targeting Fathers: Randomized Controlled Trial
    Scott, Jane Anne
    Burns, Sharyn K.
    Hauck, Yvonne L.
    Giglia, Roslyn C.
    Jorgensen, Anita M.
    White, Becky Kate
    Martin, Annegret
    Robinson, Suzanne
    Dhaliwal, Satvinder S.
    Binns, Colin W.
    Maycock, Bruce R.
    JMIR PEDIATRICS AND PARENTING, 2021, 4 (02):
  • [38] Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study
    Suhaj, A.
    Manu, M. K.
    Unnikrishnan, M. K.
    Vijayanarayana, K.
    Rao, C. Mallikarjuna
    PHARMACEUTICAL CARE ESPANA, 2016, 18 (01): : 52 - 52
  • [39] Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients a randomized controlled study
    Suhaj, A.
    Manu, M. K.
    Unnikrishnan, M. K.
    Vijayanarayana, K.
    Rao, C. Mallikarjuna
    PHARMACEUTICAL CARE ESPANA, 2016, 18 (02): : 92 - +
  • [40] Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study
    Suhaj, A.
    Manu, M. K.
    Unnikrishnan, M. K.
    Vijayanarayana, K.
    Rao, C. Mallikarjuna
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (01) : 78 - 83